FARON FARN - Inside Information: Faron Announces Encouraging First Overall Survival Data from Frontline Higher-Risk (HR) MDS Patients in the
FARON FARN - Inside Information: Faron Announces Encouraging First Overall Survival Data from Frontline Higher-Risk (HR) MDS Patients in the BEXMAB Phase 1/2 Trial
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.